• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为致病种子的tau寡聚体:体内外的制备与传播

Tau Oligomers as Pathogenic Seeds: Preparation and Propagation In Vitro and In Vivo.

作者信息

Gerson Julia E, Sengupta Urmi, Kayed Rakez

机构信息

George P. and Cynthia Woods Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, TX, 77555, USA.

Departments of Neurology, and Neuroscience and Cell Biology, University of Texas Medical Branch, Galveston, TX, 77555-1045, USA.

出版信息

Methods Mol Biol. 2017;1523:141-157. doi: 10.1007/978-1-4939-6598-4_9.

DOI:10.1007/978-1-4939-6598-4_9
PMID:27975249
Abstract

Tau oligomers have been shown to be the main toxic tau species in a number of neurodegenerative disorders. In order to study tau oligomers both in vitro and in vivo, we have established methods for the reliable preparation, isolation, and detection of tau oligomers. Methods for the seeding of tau oligomers, isolation of tau oligomers from tissue, and detection of tau oligomers using tau oligomer-specific antibodies by biochemical and immunohistochemical methods are detailed below.

摘要

在许多神经退行性疾病中,tau寡聚体已被证明是主要的毒性tau蛋白种类。为了在体外和体内研究tau寡聚体,我们已经建立了可靠制备、分离和检测tau寡聚体的方法。以下详细介绍tau寡聚体的接种方法、从组织中分离tau寡聚体以及通过生化和免疫组化方法使用tau寡聚体特异性抗体检测tau寡聚体的方法。

相似文献

1
Tau Oligomers as Pathogenic Seeds: Preparation and Propagation In Vitro and In Vivo.作为致病种子的tau寡聚体:体内外的制备与传播
Methods Mol Biol. 2017;1523:141-157. doi: 10.1007/978-1-4939-6598-4_9.
2
Tau Oligomers as Pathogenic Seeds: Preparation, Characterization, and Propagation In Vitro and In Vivo.tau 寡聚物作为致病种子:体外和体内的制备、表征、以及传播。
Methods Mol Biol. 2024;2754:147-183. doi: 10.1007/978-1-0716-3629-9_9.
3
Preparation and characterization of neurotoxic tau oligomers.神经毒性 tau 寡聚物的制备与表征。
Biochemistry. 2010 Nov 30;49(47):10039-41. doi: 10.1021/bi1016233. Epub 2010 Nov 8.
4
Biochemical Properties of Pathology-Related Tau Species in Tauopathy Brains: An Extraction Protocol for Tau Oligomers and Aggregates.tau蛋白病大脑中与病理相关的tau蛋白种类的生化特性:tau蛋白寡聚体和聚集体的提取方案
Methods Mol Biol. 2018;1779:435-445. doi: 10.1007/978-1-4939-7816-8_26.
5
Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers.利福平是一种针对淀粉样β和tau 寡聚物的候选预防药物。
Brain. 2016 May;139(Pt 5):1568-86. doi: 10.1093/brain/aww042. Epub 2016 Mar 28.
6
Tauopathies and tau oligomers.tau 病和 tau 寡聚物。
J Alzheimers Dis. 2013;37(3):565-8. doi: 10.3233/JAD-130653.
7
Potential mechanisms and implications for the formation of tau oligomeric strains.tau寡聚体菌株形成的潜在机制及影响
Crit Rev Biochem Mol Biol. 2016 Nov/Dec;51(6):482-496. doi: 10.1080/10409238.2016.1226251. Epub 2016 Sep 21.
8
Crystal structure of a conformational antibody that binds tau oligomers and inhibits pathological seeding by extracts from donors with Alzheimer's disease.阿尔茨海默病患者来源提取物中tau 寡聚体结合构象抗体的晶体结构及其对病理性播散的抑制作用
J Biol Chem. 2020 Jul 31;295(31):10662-10676. doi: 10.1074/jbc.RA120.013638. Epub 2020 Jun 3.
9
Specific targeting of tau oligomers in Htau mice prevents cognitive impairment and tau toxicity following injection with brain-derived tau oligomeric seeds.在Htau小鼠中特异性靶向tau寡聚体可预防注射脑源性tau寡聚体种子后出现的认知障碍和tau毒性。
J Alzheimers Dis. 2014;40 Suppl 1:S97-S111. doi: 10.3233/JAD-132477.
10
Preparation and Characterization of Tau Oligomer Strains.tau蛋白寡聚体菌株的制备与表征
Methods Mol Biol. 2018;1779:113-146. doi: 10.1007/978-1-4939-7816-8_9.

引用本文的文献

1
Tau Oligomers in Alzheimer's Disease: Modulation Effect of Osmolytes on Amplified Brain-Derived Tau Oligomers.阿尔茨海默病中的tau寡聚体:渗透剂对脑源性tau寡聚体扩增的调节作用
ACS Chem Neurosci. 2025 Aug 6;16(15):2829-2843. doi: 10.1021/acschemneuro.5c00122. Epub 2025 Jul 18.
2
Pathogenic oligomeric Tau alters neuronal RNA processes through the formation of nuclear heteromeric amyloids with RNA-binding protein Musashi1.致病性寡聚Tau蛋白通过与RNA结合蛋白Musashi1形成核异源淀粉样蛋白来改变神经元RNA加工过程。
Prog Neurobiol. 2025 Apr;247:102742. doi: 10.1016/j.pneurobio.2025.102742. Epub 2025 Mar 8.
3
Hippocampal Neural Stem Cell Exosomes Promote Brain Resilience against the Impact of Tau Oligomers.
海马神经干细胞外泌体促进大脑抵御 Tau 寡聚体的影响。
J Neurosci. 2025 Apr 16;45(16):e1664242025. doi: 10.1523/JNEUROSCI.1664-24.2025.
4
Amyloid-β oligomers increase the binding and internalization of tau oligomers in human synapses.β-淀粉样蛋白寡聚体增加了人突触中tau蛋白寡聚体的结合和内化。
Acta Neuropathol. 2024 Dec 17;149(1):2. doi: 10.1007/s00401-024-02839-2.
5
Inhibition of Calcineurin with FK506 Reduces Tau Levels and Attenuates Synaptic Impairment Driven by Tau Oligomers in the Hippocampus of Male Mouse Models.FK506 通过抑制钙调神经磷酸酶降低 Tau 水平,并减轻雄性小鼠模型海马区 Tau 寡聚体引起的突触损伤。
Int J Mol Sci. 2024 Aug 22;25(16):9092. doi: 10.3390/ijms25169092.
6
The Role of Tau Pathology in Alzheimer's Disease and Down Syndrome.tau蛋白病理在阿尔茨海默病和唐氏综合征中的作用。
J Clin Med. 2024 Feb 27;13(5):1338. doi: 10.3390/jcm13051338.
7
Recombinant Full-Length TDP-43 Oligomers Retain Their Ability to Bind RNAs, Are Not Toxic, and Do Not Seed TDP-43 Aggregation in Vitro.重组全长 TDP-43 寡聚物保留与其结合 RNA 的能力,本身无毒性,也不会在体外引发 TDP-43 聚集。
ACS Chem Neurosci. 2024 Jan 3;15(1):193-204. doi: 10.1021/acschemneuro.3c00691. Epub 2023 Dec 20.
8
In pursuit of degenerative brain disease diagnosis: Dementia biomarkers detected by DNA aptamer-attached portable graphene biosensor.追求退行性脑疾病的诊断:通过 DNA 适体连接的便携式石墨烯生物传感器检测痴呆生物标志物。
Proc Natl Acad Sci U S A. 2023 Nov 21;120(47):e2311565120. doi: 10.1073/pnas.2311565120. Epub 2023 Nov 13.
9
Reply: Soluble oligomers or insoluble fibrils?回复:可溶性寡聚体还是不溶性原纤维?
Acta Neuropathol. 2023 Dec;146(6):863-866. doi: 10.1007/s00401-023-02634-5. Epub 2023 Sep 21.
10
Anterograde and Retrograde Propagation of Inoculated Human Tau Fibrils and Tau Oligomers in a Non-Transgenic Rat Tauopathy Model.接种的人tau蛋白原纤维和tau蛋白寡聚体在非转基因大鼠tau蛋白病模型中的顺行和逆行传播
Biomedicines. 2023 Mar 24;11(4):1004. doi: 10.3390/biomedicines11041004.